References
El Atrache MM, Abouljoud MS, Divine G, et al. Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant. 2012;26(5):E505–12.
Guggino J, Coumes S, Wion N, et al. Effectiveness and safety of bariatric surgery in patients with end-stage chronic kidney disease or kidney transplant. Obesity (Silver Spring). 2020;28(12):2290–304.
Veroux M, Mattone E, Cavallo M, et al. Obesity and bariatric surgery in kidney transplantation: a clinical review. World J Diabetes. 2021;12(9):1563–75.
Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;104(4S1 Suppl 1):S11–103.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64(2):433–85.
Martin P, DiMartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59(3):1144–65.
de Barros F, Cardoso FaleiroUba PH. Liver transplantation and bariatric surgery: a new surgical reality: a systematic review of the best time for bariatric surgery. Updates Surg. 2021;73(5):1615–22.
Li P, Ma B, Gong S, et al. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc. 2020;34(3):1253–60.
Sharaiha RZ, Hajifathalian K, Kumar R, et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol. 2021;19(5):1051-1057.e2.
Li R, Veltzke-Schlieker W, Adler A, et al. Endoscopic sleeve gastroplasty (ESG) for high-risk patients, high body mass index (> 50 kg/m2) patients, and contraindication to abdominal surgery. Obes Surg. 2021;31(8):3400–9.
Pais R, Barritt AS 4th, Calmus Y, et al. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol. 2016;65(6):1245–57.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
G.C. is consultant for Cook Medical, Boston Scientific and Olympus. I.B. is consultant for Apollo Endosurgery, Nitinotes, Endo Tools and Cook Medical and is research grant holder from Apollo Endosurgery. All the other authors have nothing to disclose.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Matteo, M.V., Bove, V., Pontecorvi, V. et al. Endoscopic Sleeve Gastroplasty as a Therapeutic Chance for Obese Patients not Eligible for Organ Transplantation. OBES SURG 32, 2460–2462 (2022). https://doi.org/10.1007/s11695-022-06008-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-022-06008-w